Department of Internal Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran
Research Article
The Survival Of Patients With triple Negative Breast Cancer With Chemotherapy Along With Lifestyle Change Interventions In Survivors
Author(s): Adiguel Usman*
Background: The present study was conducted to examine
the survival of patients with triple negative breast cancer
subtype undergoing current chemotherapy and along with
implanting weight management, physical activity and diet in
breast cancer survivorship.
Patients and methods: The present study was conducted on
110 patients admitted to the oncology clinics of Talaghani
Hospital of Kermanshah University of Medical science
between October 2009 and July 2018. Patients started 5
chemotherapy cycles, including docetaxel, epirubicin and
cyclophosphamide once every 21 days, and then two cycles
of epirubicin and cyclophosphamide, ending with
fluorouracil. Also recommend patients for physical exercise,
diet and lifestyle change.
Results: The median and mean follow-up was 52.3 and 45.6
mo.. View More»
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 